Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Pieter A Vriesendorp"'
Publikováno v:
Lancet. 401(10383):1133-1135
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9222d11e85efab3d86bf2a43dfa0d4c
https://doi.org/10.1016/S0140-6736(23)00403-8
https://doi.org/10.1016/S0140-6736(23)00403-8
Autor:
Jason E. Bloom, Emily Andrew, Ziad Nehme, Anna Beale, Luke P. Dawson, William Y. Shi, Pieter A. Vriesendorp, Himawan Fernando, Samer Noaman, Shelley Cox, Michael Stephenson, David Anderson, William Chan, David M. Kaye, Karen Smith, Dion Stub
Publikováno v:
The American Journal of Cardiology. 177:14-21
Cardiogenic shock is associated with a high risk for morbidity and mortality. The impact of gender on treatment and outcomes is poorly defined. This study aimed to evaluate whether gender influences the clinical management and outcomes of patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::998d242f8acf48221d68331f3e796e78
https://doi.org/10.1016/j.amjcard.2022.04.047
https://doi.org/10.1016/j.amjcard.2022.04.047
Autor:
Michiel D. Vriesendorp, Rob A.F. De Lind Van Wijngaarden, Howard C. Herrmann, Stuart J. Head, Pieter A. Vriesendorp, A. Pieter Kappetein, Rolf H.H. Groenwold, Robert J.M. Klautz
Publikováno v:
Structural Heart, 5(6), 582-587. Taylor & Francis Ltd
STRUCTURAL HEART-THE JOURNAL OF THE HEART TEAM, 5(6), 582-587. TAYLOR & FRANCIS LTD
STRUCTURAL HEART-THE JOURNAL OF THE HEART TEAM, 5(6), 582-587. TAYLOR & FRANCIS LTD
Background: Prosthesis-patient mismatch (PPM), routinely used to characterize the degree of hemodynamic obstruction caused by a prosthetic heart valve, is associated with adverse patient outcomes after aortic valve replacement (AVR). In the common de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18f6b3cdacfa7f94faf9d52451041018
http://www.scopus.com/inward/record.url?scp=85121343829&partnerID=8YFLogxK
http://www.scopus.com/inward/record.url?scp=85121343829&partnerID=8YFLogxK
Autor:
Michelle Michels, Lothar Faber, Pieter A. Vriesendorp, Dieter Horstkotte, Jurriën M. ten Berg, Josef Veselka, Henning Bundgaard, Peter Riis Hansen, Hubert Seggewiss, Radka Adlová, Max Liebregts, Morten Kvistholm Jensen
Publikováno v:
Europace, 20, F198-F203. Oxford University Press
Aims The HCM Risk-SCD model for prediction of sudden cardiac death (SCD) in hypertrophic cardiomyopathy recommended by the 2014 European Society of Cardiology (ESC) guidelines has not been validated after septal reduction therapy. The aim of this stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9065105095c1ef419e89a60f5605e84d
https://pure.eur.nl/en/publications/fca46472-e797-481e-b33b-536b73d6e0f1
https://pure.eur.nl/en/publications/fca46472-e797-481e-b33b-536b73d6e0f1
Publikováno v:
Journal of the American College of Cardiology. 70:481-488
Twenty years after the introduction of alcohol septal ablation (ASA) for the treatment of obstructive hypertrophic cardiomyopathy, the arrhythmogenicity of the ablation scar appears to be overemphasized. When systematically reviewing all studies comp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8027ee16395362cf3b2efd1784f8655d
https://doi.org/10.1016/j.jacc.2017.02.080
https://doi.org/10.1016/j.jacc.2017.02.080
Autor:
Michelle Michels, Pieter A. Vriesendorp, Marjon van Slegtenhorst, Hannah G. van Velzen, Arend F.L. Schinkel, Rogier A. Oldenburg, Jolanda van der Velden
Publikováno v:
American Journal of Cardiology, 118(6), 881-887. Elsevier Inc.
van Velzen, H G, Vriesendorp, P A, Oldenburg, R A, van Slegtenhorst, M A, van der Velden, J, Schinkel, A F L & Michels, M 2016, ' Value of Genetic Testing for the Prediction of Long-Term Outcome in Patients With Hypertrophic Cardiomyopathy ', American Journal of Cardiology, vol. 118, no. 6, pp. 881-887 . https://doi.org/10.1016/j.amjcard.2016.06.038
van Velzen, H G, Vriesendorp, P A, Oldenburg, R A, van Slegtenhorst, M A, van der Velden, J, Schinkel, A F L & Michels, M 2016, ' Value of Genetic Testing for the Prediction of Long-Term Outcome in Patients With Hypertrophic Cardiomyopathy ', American Journal of Cardiology, vol. 118, no. 6, pp. 881-887 . https://doi.org/10.1016/j.amjcard.2016.06.038
Pathogenic gene mutations are found in about 50% of patients with hypertrophic cardiomyopathy (HC). Previous studies have shown an association between sarcomere mutations and medium-term outcome. The association with long-term outcome has not been de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d156f94d86f2feca9c702c1d316de4a
https://doi.org/10.1016/j.amjcard.2016.06.038
https://doi.org/10.1016/j.amjcard.2016.06.038
Autor:
Arend F.L. Schinkel, Jippe C Balt, Folkert J. ten Cate, Max Liebregts, Robbert C. Steggerda, Pieter A. Vriesendorp, Jurriën M. ten Berg, Michelle Michels
Publikováno v:
Catheterization and Cardiovascular Interventions. 88:945-952
Objectives The aim of this study is to assess the long-term effects of alcohol dosage in alcohol septal ablation (ASA) on mortality and adverse arrhythmic events (AAE). Background ASA can be performed to reduce left ventricular outflow tract (LVOT) o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d40648d3d8dffc44779fe87c946f8768
https://doi.org/10.1002/ccd.26448
https://doi.org/10.1002/ccd.26448
Autor:
Aristides Anastasakis, Zacharias Anastasiou, Rumana Z Omar, Pieter A. Vriesendorp, Constantinos O'Mahony, Pablo García-Pavía, Elena Biagini, Claudio Rapezzi, Oliver P Guttmann, Perry M. Elliott, Adrián Fernández, Kevin M.W. Leong, Michelle Michels, Giuseppe Limongelli, Juan R. Gimeno, Lorenzo Monserrat, Damiano Magrì, Amanda Varnava, Juan Pablo Ochoa, Camillo Autore, Mohammed M Akhtar
Publikováno v:
DDFV: Repositorio Institucional de la Universidad Francisco de Vitoria
Universidad Francisco de Vitoria
Heart, 105(8), 623-631. BMJ Publishing Group
DDFV. Repositorio Institucional de la Universidad Francisco de Vitoria
instname
Universidad Francisco de Vitoria
Heart, 105(8), 623-631. BMJ Publishing Group
DDFV. Repositorio Institucional de la Universidad Francisco de Vitoria
instname
ObjectiveIn 2014, the European Society of Cardiology (ESC) recommended the use of a novel risk prediction model (HCM Risk-SCD) to guide use of implantable cardioverter defibrillators (ICD) for the primary prevention of sudden cardiac death (SCD) in p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb6710ed0798af8a040b7ca3d3d1d1b7
http://hdl.handle.net/11573/1182980
http://hdl.handle.net/11573/1182980
Autor:
Arend F.L. Schinkel, Jurriën M. ten Berg, Pieter A. Vriesendorp, Max Liebregts, Michelle Michels, Bakhtawar K. Mahmoodi
Publikováno v:
JACC: Heart Failure, 3(11), 896-905. Elsevier
OBJECTIVES The aim of this meta-analysis was to compare long-term outcomes after myectomy and alcohol septal ablation (ASA) in patients with hypertrophic cardiomyopathy (HCM). BACKGROUND Surgical myectomy and ASA are both accepted treatment options f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c73f285381124297af01d68edc320ea
https://hdl.handle.net/1765/82490
https://hdl.handle.net/1765/82490
Autor:
Michelle Michels, Folkert J. ten Cate, Dominic A.M.J. Theuns, Rik Willems, Pieter A. Vriesendorp, Johan Van Cleemput, Arend F.L. Schinkel, Max Liebregts
Publikováno v:
Circulation-arrhythmia and electrophysiology, 8(4), 829-835. Lippincott Williams & Wilkins
Background— The recently released 2014 European Society of Cardiology guidelines of hypertrophic cardiomyopathy (HCM) use a new clinical risk prediction model for sudden cardiac death (SCD), based on the HCM Risk-SCD study. Our study is the first e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c62dc149f42846bb0080e99046627913
https://doi.org/10.1161/circep.114.002553
https://doi.org/10.1161/circep.114.002553